Cargando…

Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak

Background: During the lockdown period caused by the SARS-CoV-2 pandemic, we monitored via online survey the trend of allergic symptoms and the therapeutic compliance in patients followed at our center. Material and methods: In June 2020, we selected children followed at the Allergy and Immunology S...

Descripción completa

Detalles Bibliográficos
Autores principales: Brindisi, Giulia, De Vittori, Valentina, De Nola, Rosalba, Pignataro, Elia, Anania, Caterina, De Castro, Giovanna, Cinicola, Bianca, Gori, Alessandra, Cicinelli, Ettore, Zicari, Anna Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197398/
https://www.ncbi.nlm.nih.gov/pubmed/34073986
http://dx.doi.org/10.3390/jcm10112278
_version_ 1783706911070224384
author Brindisi, Giulia
De Vittori, Valentina
De Nola, Rosalba
Pignataro, Elia
Anania, Caterina
De Castro, Giovanna
Cinicola, Bianca
Gori, Alessandra
Cicinelli, Ettore
Zicari, Anna Maria
author_facet Brindisi, Giulia
De Vittori, Valentina
De Nola, Rosalba
Pignataro, Elia
Anania, Caterina
De Castro, Giovanna
Cinicola, Bianca
Gori, Alessandra
Cicinelli, Ettore
Zicari, Anna Maria
author_sort Brindisi, Giulia
collection PubMed
description Background: During the lockdown period caused by the SARS-CoV-2 pandemic, we monitored via online survey the trend of allergic symptoms and the therapeutic compliance in patients followed at our center. Material and methods: In June 2020, we selected children followed at the Allergy and Immunology Service of Umberto I Hospital, aged between 6 and 16 years old, diagnosed with asthma and/or rhinitis and sensitized to grass pollen or dust mite. We sent an email with 12 multiple-choice questions investigating several areas: type of disease and sensitization, recurrence of symptoms, medication use during lockdown compared to the same period of the previous year. Results: The results of 82 questionnaires showed that 17.8% of patients suffered from asthma, 24.4% from rhinitis, and 57.8% from both. Within the group of asthmatic children, most of them presented an improvement of their symptoms. Likewise, with regard to allergic rhinitis, most of them reported better clinical conditions. Regarding treatment, we observed a global decrease in the use of on-demand therapies (salbutamol, nasal corticosteroid, and antihistamine) for both pathologies. In addition, there was a reduction in the use of basal therapy for asthma and rhinitis from 2019 (23.3%) to 2020 (15.5%). Conclusions: Our data show a general trend of clinical improvement and a reduction in the use of on-demand and basal therapy in allergic children during the lockdown.
format Online
Article
Text
id pubmed-8197398
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-81973982021-06-13 Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak Brindisi, Giulia De Vittori, Valentina De Nola, Rosalba Pignataro, Elia Anania, Caterina De Castro, Giovanna Cinicola, Bianca Gori, Alessandra Cicinelli, Ettore Zicari, Anna Maria J Clin Med Article Background: During the lockdown period caused by the SARS-CoV-2 pandemic, we monitored via online survey the trend of allergic symptoms and the therapeutic compliance in patients followed at our center. Material and methods: In June 2020, we selected children followed at the Allergy and Immunology Service of Umberto I Hospital, aged between 6 and 16 years old, diagnosed with asthma and/or rhinitis and sensitized to grass pollen or dust mite. We sent an email with 12 multiple-choice questions investigating several areas: type of disease and sensitization, recurrence of symptoms, medication use during lockdown compared to the same period of the previous year. Results: The results of 82 questionnaires showed that 17.8% of patients suffered from asthma, 24.4% from rhinitis, and 57.8% from both. Within the group of asthmatic children, most of them presented an improvement of their symptoms. Likewise, with regard to allergic rhinitis, most of them reported better clinical conditions. Regarding treatment, we observed a global decrease in the use of on-demand therapies (salbutamol, nasal corticosteroid, and antihistamine) for both pathologies. In addition, there was a reduction in the use of basal therapy for asthma and rhinitis from 2019 (23.3%) to 2020 (15.5%). Conclusions: Our data show a general trend of clinical improvement and a reduction in the use of on-demand and basal therapy in allergic children during the lockdown. MDPI 2021-05-24 /pmc/articles/PMC8197398/ /pubmed/34073986 http://dx.doi.org/10.3390/jcm10112278 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Brindisi, Giulia
De Vittori, Valentina
De Nola, Rosalba
Pignataro, Elia
Anania, Caterina
De Castro, Giovanna
Cinicola, Bianca
Gori, Alessandra
Cicinelli, Ettore
Zicari, Anna Maria
Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak
title Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak
title_full Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak
title_fullStr Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak
title_full_unstemmed Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak
title_short Updates on Children with Allergic Rhinitis and Asthma during the COVID-19 Outbreak
title_sort updates on children with allergic rhinitis and asthma during the covid-19 outbreak
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8197398/
https://www.ncbi.nlm.nih.gov/pubmed/34073986
http://dx.doi.org/10.3390/jcm10112278
work_keys_str_mv AT brindisigiulia updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT devittorivalentina updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT denolarosalba updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT pignataroelia updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT ananiacaterina updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT decastrogiovanna updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT cinicolabianca updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT gorialessandra updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT cicinelliettore updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak
AT zicariannamaria updatesonchildrenwithallergicrhinitisandasthmaduringthecovid19outbreak